Could a common diabetes drug keep your heart in rhythm?

NCT ID NCT07187570

Recruiting now Disease control Sponsor: Region Stockholm Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tests whether dapagliflozin, a drug typically used for diabetes, can prevent atrial fibrillation from coming back after a procedure called cardioversion (an electric shock to restore normal heart rhythm). About 1600 adults with AF will take either dapagliflozin or no extra drug for up to 56 days. Researchers will track heart rhythm using a handheld device to see if the drug reduces recurrence.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: dapagliflozin (a diabetes drug that lowers blood sugar and may help heart rhythm)
What this could lead to: If it works, this could offer a new, short-term treatment to prevent atrial fibrillation from coming back after cardioversion.
What could go wrong: This is a phase 3 trial, but it's still early to know if dapagliflozin truly helps AF. The drug may not reduce recurrence, and side effects like dehydration or kidney issues are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION (AF) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

atrial fibrillation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ATRIAL FIBRILLATION (AF)

Contacts and locations

Locations

Akademiska sjukhuset
NOT_YET_RECRUITING

Uppsala, 75389, Sweden
Danderyds Hospital
NOT_YET_RECRUITING

Stockholm, 18527, Sweden
Karolinska University Hospital
RECRUITING

Stockholm, 14186, Sweden
Linköping university hosptial
NOT_YET_RECRUITING

Linköping, 58225, Sweden
Norrlands universitetssjukhus
NOT_YET_RECRUITING

Umeå, 90185, Sweden
Södersjukhuset
NOT_YET_RECRUITING

Stockholm, 11861, Sweden
Örebro University hospital
RECRUITING

Örebro, 70382, Sweden

More trials for these conditions

Other studies related to the condition(s) this trial covers.